Gut Microbial Metabolite Butyrate Regulates Treg/Th17 Cell Balance to Alleviate Diabetic Periodontitis
Journal of Clinical Periodontology · 2026-02 · 53 (2) · 321-333
DOI: 10.1111/jcpe.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 22.09.2025. Verfasst von Wenying Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Dentistry, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Resear…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Gastrointestinal Microbiome, Periodontitis, Th17 Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, The Peking University School and Hospital of Stomatology Series of Clinical Research Projects.
Abstract (Originalsprache)
Aim
To investigate whether the gut microbiota–derived metabolite butyrate alleviates the progression of diabetic periodontitis by modulating the Treg/Th17 cell balance. Materials and Methods A diabetic periodontitis mouse model was established to assess alveolar bone loss, Treg/Th17 cell subsets, colonic histopathology, faecal microbiota composition and short‐chain fatty acid (SCFA) levels. To investigate microbial causality and therapeutic potential, faecal microbiota transplantation (FMT) and butyrate supplementation were conducted.
Results
Mice with diabetic periodontitis exhibited a disrupted Treg/Th17 balance accompanied by colonic epithelial damage and a decreased abundance of SCFA‐producing gut microbiota. Faecal SCFA levels showed a downward trend, although the reduction in butyrate was not significant. FMT from diabetic periodontitis mice aggravated periodontal destruction, impaired the colonic mucus barrier and further disturbed Treg/Th17 homeostasis in the recipient mice. These effects were associated with a decrease in SCFA‐producing bacteria and faecal butyrate levels. Moreover, butyrate supplementation significantly alleviated periodontal destruction and restored the Treg/Th17 balance.
Conclusion
Gut microbiota dysbiosis contributes to diabetic periodontitis progression through disruption of the Treg/Th17 balance, whereas butyrate, as an immunomodulatory SCFA, may alleviate periodontal tissue destruction by restoring this balance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Dentistry, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of…
- Department of Periodontology, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral B…
ORCID-Profile: Jing Diao
Förderung
- National Key Research and Development Program of China
- The Peking University School and Hospital of Stomatology Series of Clinical Research Projects
Zitieren
APA
Yang, W., Zhang, Y., Xu, Y., Diao, J., Zheng, S., & Yuan, C. (2026). Gut Microbial Metabolite Butyrate Regulates Treg/Th17 Cell Balance to Alleviate Diabetic Periodontitis. Journal of Clinical Periodontology, 53(2), 321-333. https://doi.org/10.1111/jcpe.70041
Vancouver
Yang W, Zhang Y, Xu Y, Diao J, Zheng S, Yuan C. Gut Microbial Metabolite Butyrate Regulates Treg/Th17 Cell Balance to Alleviate Diabetic Periodontitis. Journal of Clinical Periodontology. 2026;53(2):321-333. doi:10.1111/jcpe.70041
BibTeX
@article{Yang2026,
author = {Yang, Wenying and Zhang, Yanling and Xu, Yifan and Diao, Jing and Zheng, Shuguo and Yuan, Chao},
title = {Gut Microbial Metabolite Butyrate Regulates Treg/Th17 Cell Balance to Alleviate Diabetic Periodontitis},
journal = {Journal of Clinical Periodontology},
year = {2026},
volume = {53},
number = {2},
pages = {321--333},
doi = {10.1111/jcpe.70041}
}
EUVIMED